Organometallic Ligands

<p>2-[1-[(2-Amino-7H-purin-6-yl)amino]ethyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one is a synthetic pharmaceutical compound, classified as a small molecule inhibitor. It is derived from a combination of purine and quinazoline structures, typically synthesized through multi-step organic processes. This compound exhibits its mode of action by specifically targeting and inhibiting certain key enzymes or receptors within cellular pathways, potentially interfering with aberrant signaling processes. Through this mechanism, it can modulate biological activity, offering a pathway to correct dysregulated cellular environments.</p>

<p>Beraprost sodium is a synthetic analog of prostacyclin, which is derived from chemical synthesis. It acts by binding to the prostacyclin (IP) receptors on the surface of vascular endothelial cells and platelets, leading to an increase in cyclic adenosine monophosphate (cAMP) levels. This biochemical cascade results in vasodilation, inhibition of platelet aggregation, and anti-proliferative effects on smooth muscle cells.</p>

<p>Imidazo[1,2-a]pyridin-2(3H)-one is a heterocyclic compound, which is a member of the imidazopyridine class. This compound is synthesized through various organic reactions involving the cyclization of precursor molecules, often incorporating nitrogen atoms into its ring structure. Its mode of action typically involves interaction with specific biological targets, such as receptors or enzymes, where it can modulate physiological responses. The compound acts through binding at allosteric sites, often influencing the activity of central nervous system receptors or enzymes involved in cellular signaling pathways.</p>

<p>Please enquire for more information about TJ191 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Cbp/P300-in-3 is a small molecule inhibitor, which is synthesized in vitro. It functions by selectively inhibiting the CBP/p300 family of histone acetyltransferases (HATs), essential regulatory proteins involved in chromatin remodeling and transcriptional activation. The inhibitor binds to the active site of these enzymes, hindering their activity, thereby disrupting the acetylation of histones and other substrates.</p>

<p>Please enquire for more information about Nsah including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>RVT 501 is a biochemical reagent, which is derived from synthetic organic compounds with high specificity. Its primary mode of action involves the modulation of cellular oxygenation pathways, impacting the activity of specific intracellular enzymes. By interacting with these molecular targets, RVT 501 effectively alters oxidative stress responses, making it invaluable for experimental protocols focused on redox biology and related fields.</p>

<p>CYM 50769 is an agricultural fungicide, which is a synthetic chemical compound designed to protect crops from fungal infections. It originates from extensive laboratory research and development processes aimed at targeting and neutralizing specific fungal threats that affect agricultural yield and quality. The mode of action of CYM 50769 involves the inhibition of essential fungal metabolic pathways, thereby preventing the growth and proliferation of the fungus. This mechanism disrupts the pathogen's ability to reproduce and colonize plant tissues, effectively controlling the spread of the disease.</p>

<p>Dihydrocyclosporin A is an immunosuppressant, which is a cyclic undecapeptide derived from fungal metabolites, specifically from the soil fungus Tolypocladium inflatum. This compound functions through the inhibition of calcineurin, which is a crucial phosphatase involved in the activation of T-cells. By binding to the intracellular protein cyclophilin, Dihydrocyclosporin A forms a complex that inhibits calcineurin activity, subsequently blocking the transcription of interleukin-2 and other cytokines essential for T-cell proliferation.</p>

<p>AVN-492 is an anti-inflammatory compound, derived from specific medicinal plant sources. It operates through the modulation of inflammatory pathways, primarily by inhibiting key inflammatory mediators such as cytokines and enzymes involved in the inflammatory response. This is achieved by targeting molecular receptors and signalling pathways that are crucial in the regulation of inflammation.</p>

<p>Penicillin (human) is a beta-lactam antibiotic, which is derived from the Penicillium fungi. Its mode of action involves inhibiting the synthesis of peptidoglycan, an essential component of bacterial cell walls. This disruption in cell wall synthesis leads to cell lysis and ultimately bacterial cell death, making it particularly effective against Gram-positive bacteria.</p>

<p>1-[4-[6-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]pyridin-2-yl]piperidin-4-ol is a bioactive small molecule, typically synthesized in laboratories focusing on medicinal chemistry. This compound is specifically designed to interact with biochemical targets, usually proteins or receptors, to modulate their activity. Its mode of action involves binding to specific sites on these targets, potentially leading to inhibition, activation, or alteration of the target's natural function, depending on the desired therapeutic outcome. The applications of this compound are mainly situated in the realm of drug discovery and development, serving as a lead or candidate in the pursuit of effective therapies for conditions that involve the targeted pathways or receptors. Researchers analyze such compounds to assess their efficacy, selectivity, and therapeutic potential in disease models, which is critical in the preclinical stage of drug development.</p>

<p>Procaterol is a bronchodilator, which is a synthetic beta-2 adrenergic agonist. It is derived through chemical processes designed to specifically target the beta-2 adrenergic receptors located in the bronchial smooth muscle. The mode of action involves the activation of these receptors, which leads to the relaxation of bronchial smooth muscles. This relaxation effect facilitates the widening of airways, improving airflow and respiratory function.</p>

<p>Calcitonin (salmon) trifluoroacetate is a synthetic peptide analogue of the naturally occurring hormone calcitonin. It is derived from salmon, which is a rich source of calcitonin known for its higher potency compared to human calcitonin. This peptide functions by inhibiting osteoclast activity, which are the cells responsible for bone resorption. It achieves this by binding to specific receptors on osteoclasts, thus reducing bone turnover and lowering calcium levels in the blood.</p>

<p>Ns-3-008 hydrochloride is a synthetic research compound, which is derived from laboratory-based chemical synthesis. It acts primarily as an inhibitor of specific biological targets, potentially interfering with cellular signaling pathways. The mode of action of Ns-3-008 hydrochloride often involves binding to and inhibiting key enzymes or receptors that play critical roles in disease-related processes.</p>

<p>MSX-122 is a small-molecule inhibitor, which is synthetically derived through pharmaceutical research. It functions as an antagonist to hypoxia-inducible factor-1α (HIF-1α), a transcription factor pivotal in cellular response to low oxygen conditions. By inhibiting HIF-1α, MSX-122 effectively disrupts the transcriptional activation of genes involved in angiogenesis, metabolism, and survival pathways that are often upregulated in cancerous tissues.</p>

<p>Ent-ticagrelor is a chirally pure pharmaceutical compound, categorized as a P2Y12 receptor antagonist, derived synthetically. This stereoisomer exemplifies the principle of stereochemistry in drug development, focusing on molecular specificity. Its mode of action involves selective binding to the P2Y12 adenosine diphosphate (ADP) receptors on platelets. This binding effectively inhibits the ADP-mediated activation of the GPIIb/IIIa receptor complex, which is crucial for platelet aggregation and clot formation.</p>

<p>Namitecan is a semi-synthetic camptothecin derivative, derived primarily from the bark of the Camptotheca acuminata tree, a source known for potent antitumor properties. Its mode of action involves the inhibition of DNA topoisomerase I, an enzyme critical for DNA replication. By stabilizing the covalent bond between DNA and topoisomerase I during the replication process, Namitecan effectively induces DNA damage, resulting in apoptosis of rapidly dividing tumor cells.</p>

<p>GSK J4 HCl is a small-molecule inhibitor, which is derived from synthetic chemistry methods, designed specifically to target the histone demethylase JMJD3/UTX. This compound functions by inhibiting the activity of the enzyme, effectively modulating epigenetic modifications through its influence on histone demethylation processes.</p>

<p>Lin28-let-7a antagonist 1 is a small molecule inhibitor, which is a chemically synthesized compound with significant therapeutic potential. It acts by targeting the Lin28/let-7 axis, a critical regulatory pathway involved in cellular processes such as development, metabolism, and tumorigenesis. The source of this antagonist is a synthetic, rationally designed compound, optimized for high specificity and potency.</p>

<p>N-Acetylpurinomycin is an antibiotic compound, which is a naturally occurring substance derived from microbial sources, specifically certain strains of the Streptomyces genus. The mode of action of N-Acetylpurinomycin involves inhibition of protein synthesis by targeting ribosomal RNA, thereby disrupting the translation process in bacterial cells. This mechanism is akin to several aminoglycoside antibiotics, whereby binding to the ribosome interferes with the fidelity of mRNA translation, leading to the incorporation of incorrect amino acids into proteins and the inhibition of bacterial growth.</p>

<p>NCX1022 is a novel anti-inflammatory compound, which is a nitric oxide-releasing glucocorticoid. This product originates from the integration of glucocorticoids, known for their potent immunosuppressive and anti-inflammatory properties, with nitric oxide (NO) donors. The mode of action involves the dual-release mechanism where the glucocorticoid exerts its effects by binding to the intracellular glucocorticoid receptor, inhibiting the transcription of pro-inflammatory cytokines, while the nitric oxide component facilitates vasodilation and additional anti-inflammatory effects through the modulation of blood flow and reduction of oxidative stress.</p>

<p>Non-transportable inhibitor of GLT-1 glutamate transporter</p>

<p>ZnAF-2 is a specialized chemical compound known as a zinc-based antimicrobial agent. It is synthesized through a controlled chemical process involving zinc ions coordinated with specific ligand structures, which contribute to its stability and reactivity. The primary mode of action for ZnAF-2 involves the disruption of microbial cellular structures, specifically targeting cell wall synthesis and membrane integrity. This mechanism allows it to effectively inhibit the growth and proliferation of a wide range of pathogenic microorganisms, including bacteria and fungi.</p>

<p>CUDC-427 is a small-molecule inhibitor of apoptosis proteins (IAP), which is a synthetic compound sourced from the design and synthesis of targeted anticancer agents. Its primary mode of action involves the selective inhibition of IAPs, particularly cIAP1 and cIAP2. This inhibition leads to the activation of caspases and subsequent induction of apoptosis in cancer cells.</p>

<p>IQ 1S is an advanced writing instrument, which is an innovation in sensor-integrated pens developed from cutting-edge optoelectronic engineering. With the integration of highly sensitive, miniaturized sensors and a sophisticated feedback system, IQ 1S provides users with real-time analysis and metadata collection while writing. This instrument utilizes a combination of pressure sensors and accelerometers to capture comprehensive writing data, including pressure, angle, and velocity.</p>

<p>Y-33075 dihydrochloride is a potent selective Rho-associated kinase (ROCK) inhibitor, which is synthesized chemically. It specifically targets ROCK enzymes involved in the regulation of the cytoskeleton by phosphorylating proteins that control smooth muscle contraction, cell migration, and other critical cellular processes. Y-33075 dihydrochloride works by inhibiting the ROCK pathway, leading to alterations in cell shape, motility, and apoptosis.</p>

<p>[(2R)-2-[(E)-But-2-enoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate is a synthetic phospholipid, which is derived from designed chemical synthesis. With its amphiphilic nature, this compound integrates into lipid bilayers, enhancing membrane permeability. It serves as an effective vector for drug delivery, facilitating the transport of therapeutic agents across cellular membranes.</p>

<p>Ifn alpha-ifnar-in-1 hydrochloride is a synthetic small molecule, which is derived from chemical synthesis with a focus on disrupting specific cytokine signaling pathways. This compound operates by selectively inhibiting the interaction between interferon-alpha (IFN-α) and its receptor, IFNAR, thereby blocking downstream JAK-STAT signaling pathways. The blockade of this signaling cascade is crucial in modulating immune responses, which are often dysregulated in various pathologies.</p>

<p>BIIE 0246 is a selective neuropeptide Y (NPY) Y2 receptor antagonist, which is a synthetic compound with specific applications in neuroscience research. This product is derived from combinatorial chemistry techniques that allow for precise structure-activity relationship studies.</p>

<p>Protac BRD9 Degrader-1 is a small molecule degrader, which is a bifunctional molecule derived from proteolysis-targeting chimera (PROTAC) technology. It operates by harnessing the ubiquitin-proteasome system to selectively degrade the BRD9 protein. The molecule consists of two ligands: one binds to the target protein, BRD9, and the other recruits an E3 ubiquitin ligase. This forms a ternary complex, leading to the ubiquitination and subsequent degradation of BRD9.</p>

<p>PF-3758309 is a small molecule inhibitor, which is identified as a product of synthetic chemical engineering. It acts as a potent inhibitor of the PAK kinases, particularly PAK4, a family of serine/threonine kinases involved in cytoskeletal dynamics, cell motility, survival, and proliferation. These kinases are overexpressed in various types of cancer, making them attractive targets for therapeutic intervention.</p>

<p>Pyr6 is a small molecule inhibitor, which is derived from synthetic organic chemistry with a specific mode of action targeting signaling pathways. Its main mechanism involves the inhibition of transient receptor potential (TRP) channels, specifically TRPV6, which plays a critical role in calcium influx in cells. By inhibiting TRPV6, Pyr6 effectively disrupts calcium signaling, which is pivotal in various cellular processes, including proliferation and differentiation.</p>

<p>1-Desoxymethylsphingosine is a synthetic compound, which is derived from sphingosine analogs, designed for research purposes. As a chemical entity, it is typically synthesized in laboratories specializing in lipid chemistry. The mode of action of 1-Desoxymethylsphingosine involves the inhibition of enzymes involved in sphingolipid metabolism, primarily targeting the sphingosine kinase pathway. This inhibition affects the regulation of bioactive sphingolipids, which play crucial roles in cell signaling and apoptosis.</p>

<p>RMC-4550 is an adhesive compound, which is a synthetic formulation with high-performance bonding capabilities. It is derived from an optimized blend of polymers, designed to enhance its adhesion and tensile strength on diverse substrates. The mode of action involves forming molecular interactions and mechanical interlocks with the surfaces it bonds, which provides exceptional resistance to environmental degradation and mechanical stress.</p>

<p>2-(Phosphonomethyl)-pentanedioic acid tetrasodium is a synthetic compound, which is an organophosphorus chemical designed for specific biochemical applications. Its source lies in the realm of chemical synthesis involving the phosphorylation of organic moieties, leading to its unique structural configuration.</p>

<p>Please enquire for more information about Fosteabine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>The USP7/USP47 inhibitor is a small molecule inhibitor, which is a synthetic compound designed to interrupt specific protein functions. It is sourced through chemical synthesis processes that enable precise modulation of the ubiquitin-proteasome system. The mode of action involves the inhibition of USP7 (ubiquitin-specific protease 7) and USP47, which are enzymes with deubiquitinating activity. By preventing these enzymes from removing ubiquitin tags from substrate proteins, the inhibitor promotes protein degradation.</p>

<p>MSC 2032964A is a synthetic small molecule compound, which is derived from a complex multi-step chemical synthesis process. It functions as an inhibitor of specific enzymatic pathways within cellular processes, displaying selectivity based on molecular interactions at the binding site.</p>

<p>(R)-5-Fluoro-N-(4-fluoro-3-(3-imino-2,5-dimethyl-1,1-dioxido-1,2,4-thiadiazinan-5-yl)phenyl)picolinamide 2,2,2-trifluoroacetate is a sophisticated chemical compound, primarily utilized in the field of pharmaceutical research. Derived from synthetic organic chemical processes, this compound represents a class of advanced heteroaryl amides with potential bioactive properties. Its unique mode of action is centered on its ability to engage in binding interactions, presumably with specific protein targets or enzymes, influencing molecular pathways related to disease states.</p>

<p>DCG IV is a sophisticated fourth-generation tyrosine kinase inhibitor, which is synthesized through advanced medicinal chemistry techniques. Its mode of action involves the selective targeting and inhibition of specific tyrosine kinases that are aberrantly active in certain malignancies. By binding to the ATP-binding sites of these kinases, DCG IV effectively disrupts the signaling pathways that are crucial for cancer cell proliferation and survival.</p>

<p>ABP 688 is a radiolabeled ligand, which is a synthetic compound used primarily in positron emission tomography (PET) to visualize metabotropic glutamate receptor subtype 5 (mGluR5) in vivo. Developed from chemical synthesis, ABP 688 acts by selectively binding to the allosteric site of the mGluR5 receptor with high affinity and specificity. When labeled with a positron-emitting isotope such as Carbon-11 or Fluorine-18, it allows for the non-invasive imaging and quantification of mGluR5 distribution and density in the brain.</p>

<p>N-(3-Bromophenyl)-1H-imidazo[4,5-G]quinazolin-8-amine, hydrochloride is a small molecule inhibitor, which is typically sourced from chemical synthesis performed under controlled laboratory conditions. This compound operates as a selective inhibitor targeting specific signaling pathways, such as those involving kinases that are often upregulated in cancerous cells. By interfering with these pathways, the compound can effectively disrupt cellular proliferation, making it a valuable tool for understanding cancer cell biology.</p>

<p>Please enquire for more information about UC-514321 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>BTZO 1 is an advanced biochemical reagent, typically derived through complex organic synthesis. It operates primarily by interacting with specific biochemical pathways, acting as either a catalyst or inhibitor depending on the surrounding conditions and the target system. This dual functionality allows for precise modulation of biochemical processes, making it highly versatile in laboratory settings.</p>

<p>FASN-IN-3 is a chemical compound that functions as a selective inhibitor of fatty acid synthase (FASN), which is an enzyme crucial for the biosynthesis of fatty acids. It is typically synthesized through complex organic chemistry techniques aimed at robust and precise inhibitory action. The mode of action involves the potent binding to the FASN enzyme, thereby obstructing its activity. This disruption hinders the conversion of acetyl-CoA and malonyl-CoA into long-chain fatty acids, a process vital for cellular lipid synthesis and energy storage.</p>

<p>4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-ol is a synthetic chemical compound with potential applications in biomedical research. This compound is derived from purine, which is a molecule that plays a critical role in various biological processes, including the synthesis of nucleic acids. The presence of the triazole group in its structure enhances the compound's capacity for diverse chemical interactions, making it a versatile tool in experimental settings.</p>

<p>3-Methyl-1-trityl-1H-1,2,4-triazole is a chemical compound that belongs to the class of triazole derivatives. It is synthesized in a laboratory setting through organic synthesis techniques, involving the tritylation of a triazole moiety. Its mode of action is primarily centered on its triazole ring, which is known to interact with a variety of biological targets, potentially affecting enzymatic functions and inhibiting certain pathways. Due to its unique structure, this compound is of interest in medicinal chemistry for its possible role as a bioactive agent. Applications include its use as a research tool in the study of enzyme inhibition, exploring new therapeutic pathways, and as a scaffold for the development of more complex bioactive molecules. Its structure allows for modifications that can yield analogs with diverse biological activities, making it a valuable compound for scientists working in drug discovery and development.</p>

<p>(+)-Azasetron hydrochloride is a chemical compound known as a 5-HT3 receptor antagonist, which is synthesized through chemical processes. Its primary mode of action involves the selective inhibition of the serotonin 5-HT3 receptor, located in both the central and peripheral nervous systems. This block prevents serotonin from binding to its receptor, which is a crucial step in the emetic response—a physiological reaction that leads to nausea and vomiting.</p>

<p>Neopatulin is a naturally occurring compound classified as a bioactive agent, which is derived from certain species of fungi, particularly from Penicillium. Its mode of action involves disrupting microbial cell function, making it effective as an antimicrobial agent. The compound interferes with cell wall synthesis and metabolic processes of the microorganisms, ultimately inhibiting their growth and proliferation.<br><br>Neopatulin is utilized primarily in research settings to explore its potential applications in controlling microbial growth in various contexts, ranging from food preservation to pharmaceutical development. Its ability to inhibit a broad spectrum of pathogens highlights its importance in studies focusing on food safety and infectious disease control. Ongoing research is investigating its efficacy and safety profile, with an aim to strategically harness its antimicrobial properties while minimizing any potential adverse effects. As such, Neopatulin serves as a potent tool for scientists aiming to develop innovative solutions for microbial resistance and other challenges in microbiology and biotechnology.</p>